nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acid-fast bacterium-Escherichia coli shuttle vector; gene cloning and expression in e.g. Mycobacterium bovis BCG for multivalent recombinant vaccine production, e.g. against Mycobacterium tuberculosis or hepatitis B virus
|
|
|
1993 |
11 |
9 |
p. 981- 1 p. |
artikel |
2 |
Antigenicity of a candidate varicella-zoster virus glycoprotein subunit vaccine
|
Vafai, Abbas |
|
1993 |
11 |
9 |
p. 937-940 4 p. |
artikel |
3 |
Anti-polyribosyl-ribitol phosphate and anti-N. meningitidis outer membrane protein antibody levels following PRP—OMP conjugate vaccination
|
Wong, Victor K. |
|
1993 |
11 |
9 |
p. 979-980 2 p. |
artikel |
4 |
Assessment of non-protein impurities in potential vaccine proteins produced by Bacillus subtilis
|
Himanen, Juha-Pekka |
|
1993 |
11 |
9 |
p. 970-973 4 p. |
artikel |
5 |
Calendar
|
|
|
1993 |
11 |
9 |
p. 984- 1 p. |
artikel |
6 |
Can one predict antigenic peptides for MHC class I-restricted cytotoxic T lymphocytes useful for vaccination?
|
Calin-Laurens, Véronique |
|
1993 |
11 |
9 |
p. 974-978 5 p. |
artikel |
7 |
Chimeric protein capable of forming capsid assembly; phage MS-2 recombinant coat protein production following Cys residue relocation in protuberant hairpin and disulfide bond formation; potential empty capsid recombinant vaccine production
|
|
|
1993 |
11 |
9 |
p. 981- 1 p. |
artikel |
8 |
Comparison of enhanced chemiluminescence and microparticle enzyme immunoassay for the measurement of hepatitis B surface antibody
|
McCartney, R.A. |
|
1993 |
11 |
9 |
p. 941-945 5 p. |
artikel |
9 |
DNA encoding infectious-Venezuelan-horse-encephalitis virus RNA; used to prepare live attenuated togavirus for use as a recombinant vaccine
|
|
|
1993 |
11 |
9 |
p. 982- 1 p. |
artikel |
10 |
Dog distemper virus vaccine; comprises immunogen from virus-infected CCL-64 mink lung CCI-64 cell culture in serum-free culture medium
|
|
|
1993 |
11 |
9 |
p. 982- 1 p. |
artikel |
11 |
Feline lymphoid cell lines producing feline immunodeficiency virus; cat lymphoid cell line FeT-1M, FeT-2D, FL-4, FL-6, FIV production; may be used for vaccine for protection against FIV virus infection in cat
|
|
|
1993 |
11 |
9 |
p. 981-982 2 p. |
artikel |
12 |
Human leucocyte antigens (HLA) in neonates with an inadequate response to hepatitis B vaccination
|
del Canho, R. |
|
1993 |
11 |
9 |
p. 983- 1 p. |
artikel |
13 |
Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene
|
Weijer, Kees |
|
1993 |
11 |
9 |
p. 946-956 11 p. |
artikel |
14 |
Induction of T-cell immunity to oligosaccharide antigens immobilized on crystalline bacterial surface layers (S-layers)
|
Smith, Richard H. |
|
1993 |
11 |
9 |
p. 919-924 6 p. |
artikel |
15 |
Infectious-hematopoietic-necrosis virus G protein DNA; expression in Escherichia coli using vector plasmid pG8 for potential recombinant vaccine production for use against salmonoid infection
|
|
|
1993 |
11 |
9 |
p. 981- 1 p. |
artikel |
16 |
Influenza vaccines: the effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period. A review of the literature
|
Palache, A.M. |
|
1993 |
11 |
9 |
p. 892-908 17 p. |
artikel |
17 |
Intestinal antibody response after oral immunization with a prototype cholera B subunit — colonization factor antigen enterotoxigenic Escherichia coli vaccine
|
Åhrén, Christina |
|
1993 |
11 |
9 |
p. 929-934 6 p. |
artikel |
18 |
Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles
|
O'Hagan, D.T. |
|
1993 |
11 |
9 |
p. 965-969 5 p. |
artikel |
19 |
Non-lymphoid continuous cell line; Eimeria tenella recombinant antigen production in new continuous SB-CEV1/p, SB-CEV-1/F7 or SB-CEV-1/G7 cell culture; recombinant vaccine against fowl coccidiosis
|
|
|
1993 |
11 |
9 |
p. 981- 1 p. |
artikel |
20 |
Oral vaccination of racoons (Procyon lotor) with baculovirus-expressed rabies virus glycoprotein
|
Fu, Zhen Fang |
|
1993 |
11 |
9 |
p. 925-928 4 p. |
artikel |
21 |
Pilot evaluation of influenza virus vaccine (IVV) combined with adjuvant
|
Keitel, W. |
|
1993 |
11 |
9 |
p. 909-913 5 p. |
artikel |
22 |
Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA
|
Robinson, H.L. |
|
1993 |
11 |
9 |
p. 957-960 4 p. |
artikel |
23 |
Protection of goats against peste des petits ruminants with a vaccinia virus double recombinant expressing the F and H genes of rinderpest virus
|
Jones, L. |
|
1993 |
11 |
9 |
p. 961-964 4 p. |
artikel |
24 |
Sheep Jaagsiekte retrovirus cDNA sequence, new antibody and probe of a new pulmonary-adenomatosis virus application in diagnosis and vaccine production
|
|
|
1993 |
11 |
9 |
p. 982- 1 p. |
artikel |
25 |
Studies on the toxicities of aluminium hydroxide and calcium phosphate as immunological adjuvants for vaccines
|
Goto, Norihisa |
|
1993 |
11 |
9 |
p. 914-918 5 p. |
artikel |
26 |
Tetanus immunity among Italians born after the introduction of mandatory vaccination of children
|
D'Amelio, Raffaele |
|
1993 |
11 |
9 |
p. 935-936 2 p. |
artikel |
27 |
Vaccine therapy for HIV: A historical review of the treatment of infectious diseases by active specific immunization with microbe-derived antigens
|
Burke, Donald S. |
|
1993 |
11 |
9 |
p. 883-891 9 p. |
artikel |